Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lauer

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Virology|May 28, 2004
Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virusMarie Larsson, Ethan Babcock, Arash Grakoui, et al.
The Journal of General Virology|January 8, 2010
Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversityKarina Yusim, William Fischer, Hyejin Yoon, et al.
The Lancet. Infectious Diseases|May 1, 2012
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineJason Grebely, Maria Prins, Margaret Hellard, et al.
Hepatology (Baltimore, Md.)|January 26, 2008
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiationJohn W Northfield, Victoria Kasprowicz, Michaela Lucas, et al.
AIDS (London, England)|July 19, 2023
Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in ZambiaGuy K Muula, Samuel Bosomprah, Edford Sinkala, et al.
Biomarkers in Medicine|July 5, 2022
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patientsAkif Altinbas, Jacinta A Holmes, Shadi Salloum, et al.
Frontiers in Medicine|May 16, 2018
Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus TherapyDahlene N Fusco, Lilia Ganova-Raeva, Yury Khudyakov, et al.
Hepatology (Baltimore, Md.)|November 14, 2025
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategiesRebecca Strain, Matthew Edmans, Gerardo Montalvo Zurbia-Flores, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2023
Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in ZambiaMichael J Vinikoor, Kalongo Hamusonde, Guy Muula, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Virology|May 28, 2004
Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virusMarie Larsson, Ethan Babcock, Arash Grakoui, et al.
The Journal of General Virology|January 8, 2010
Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversityKarina Yusim, William Fischer, Hyejin Yoon, et al.
The Lancet. Infectious Diseases|May 1, 2012
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineJason Grebely, Maria Prins, Margaret Hellard, et al.
Hepatology (Baltimore, Md.)|January 26, 2008
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiationJohn W Northfield, Victoria Kasprowicz, Michaela Lucas, et al.
AIDS (London, England)|July 19, 2023
Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in ZambiaGuy K Muula, Samuel Bosomprah, Edford Sinkala, et al.
Biomarkers in Medicine|July 5, 2022
LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patientsAkif Altinbas, Jacinta A Holmes, Shadi Salloum, et al.
Frontiers in Medicine|May 16, 2018
Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus TherapyDahlene N Fusco, Lilia Ganova-Raeva, Yury Khudyakov, et al.
Hepatology (Baltimore, Md.)|November 14, 2025
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategiesRebecca Strain, Matthew Edmans, Gerardo Montalvo Zurbia-Flores, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2023
Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in ZambiaMichael J Vinikoor, Kalongo Hamusonde, Guy Muula, et al.
Journal of Hepatology|March 8, 2022
Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infectionAdam J Gehring, Patricia Mendez, Kirsten Richter, et al.
Pageof 2